Eicosapentaenoic acid and aspirin, alone and in combination, for the prevention of colorectal adenomas (seAFOod Polyp Prevention trial): a multicentre, randomised, double-blind, placebo-controlled, 2 × 2 factorial trial. (2018)
Attributed to:
A randomised controlled trial of eicosapentaenoic acid (EPA) and/or aspirin for colorectal adenoma (or polyp) preve
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s0140-6736(18)31775-6
PubMed Identifier: 30466866
Publication URI: http://europepmc.org/abstract/MED/30466866
Type: Journal Article/Review
Volume: 392
Parent Publication: Lancet (London, England)
Issue: 10164
ISSN: 0140-6736